[HTML][HTML] Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
…, DK Hossfeld, C Nerl, GM Baerlocher, D Heim… - …, 2019 - ncbi.nlm.nih.gov
Standard first-line therapy of chronic myeloid leukemia is treatment with imatinib. In the
randomized German Chronic Myeloid Leukemia-Study IV, more potent BCR-ABL inhibition with …
randomized German Chronic Myeloid Leukemia-Study IV, more potent BCR-ABL inhibition with …
Akute lymphoblastische leukämie–Diagnostik und Therapie
M Medinger, D Heim, C Lengerke, JP Halter… - Ther …, 2019 - econtent.hogrefe.com
Die Akute Lymphoblastische Leukämie (ALL) ist eine seltene maligne, hämatologische
Erkrankung. Der Häufigkeitsgipfel liegt im Kindesalter und ist im Erwachsenenalter selten; was …
Erkrankung. Der Häufigkeitsgipfel liegt im Kindesalter und ist im Erwachsenenalter selten; was …
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a …
…, AR Zander, L Volin, T Ruutu, DA Heim… - The lancet …, 2009 - thelancet.com
Background Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality
after allogeneic haematopoietic cell transplantation from unrelated donors. Anti-T-cell …
after allogeneic haematopoietic cell transplantation from unrelated donors. Anti-T-cell …
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or-intolerant chronic myeloid leukemia in accelerated phase
…, CA de Souza, JH Lipton, A Hochhaus, D Heim… - blood, 2007 - ashpublications.org
Abstract Treatment options are limited for patients with imatinib-resistant or -intolerant
accelerated phase chronic myeloid leukemia (CML-AP). Dasatinib is a novel, potent, oral, …
accelerated phase chronic myeloid leukemia (CML-AP). Dasatinib is a novel, potent, oral, …
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG …
…, AR Zander, L Volin, T Ruutu, DA Heim… - Blood, The Journal …, 2011 - ashpublications.org
Previous randomized graft-versus-host disease (GVHD)-prophylaxis trials have failed to
demonstrate reduced incidence and severity of chronic GVHD (cGVHD). Here we reanalyzed …
demonstrate reduced incidence and severity of chronic GVHD (cGVHD). Here we reanalyzed …
[HTML][HTML] Rituximab in B-lineage adult acute lymphoblastic leukemia
S Maury, S Chevret, X Thomas, D Heim… - … England Journal of …, 2016 - Mass Medical Soc
Background Treatment with rituximab has improved the outcome for patients with non-Hodgkin’s
lymphoma. Patients with B-lineage acute lymphoblastic leukemia (ALL) may also have …
lymphoma. Patients with B-lineage acute lymphoblastic leukemia (ALL) may also have …
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib …
…, GM Baerlocher, G Ehninger, D Heim… - Journal of clinical …, 2014 - ascopubs.org
Purpose Deep molecular response (MR 4.5 ) defines a subgroup of patients with chronic
myeloid leukemia (CML) who may stay in unmaintained remission after treatment …
myeloid leukemia (CML) who may stay in unmaintained remission after treatment …
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
JR Passweg, A Tichelli, S Meyer-Monard, D Heim… - Leukemia, 2004 - nature.com
This pilot study tested feasibility of natural killer cell purification and infusion (NK-DLI) in
patients after haploidentical hematopoietic stem cell transplantation (HSCT). The aim was to …
patients after haploidentical hematopoietic stem cell transplantation (HSCT). The aim was to …
Surgical treatment of humeral shaft fractures—the Basel experience
D Heim, F Herkert, P Hess… - Journal of Trauma and …, 1993 - journals.lww.com
One hundred twenty seven patients with fractures of the humeral shaft were treated by open
reduction and internal fixation using 4.5-mm dynamic compression plates (DCP). Seventy …
reduction and internal fixation using 4.5-mm dynamic compression plates (DCP). Seventy …
[HTML][HTML] Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease
Cytomegalovirus (CMV) infection and graft-versus-host disease (GVHD) are important
complications after allogeneic hematopoietic stem cell transplantation (HSCT) with a clear link. …
complications after allogeneic hematopoietic stem cell transplantation (HSCT) with a clear link. …